February
14, 2008--Novartis
announced that the head of its North American pharmaceuticals
unit, Alex Gorsky, has resigned. Gorsky will return to Johnson
& Johnson, where he worked before joining Novartis. Reuters
Genstruct: Patience, Persistence, and Payoff By John Russell
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
PharmaWeek is subject to the terms and conditions
of use.
Please read the important legal notices and disclaimers contained in
these terms and conditions
of use.
Copyright 2005
Cambridge Healthtech
Institute | 250 First Avenue | Suite 300 |
Needham, MA 02494
Phone: 781-972-5400 | Fax: 781-972-5425
